Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Lee Jennifer Kayden. Officer active across 1 company, notably Rhythm Pharmaceuticals, INC.. Cumulatively, 16 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €1m. History available since 7 August 2023. The latest transaction was filed on 12 February 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
5,500 sharesCommon StockSEC:0001104659-25-015320:0
600 shares@ US$56.392.4% of flowCommon StockSEC:0001104659-25-014257:0
3,437 sharesCommon StockSEC:0001104659-25-011677:0
1,733 shares@ US$60.08117.5% of flowCommon StockSEC:0001104659-25-010610:0
4,513 sharesCommon StockSEC:0001104659-25-009284:0
20,622 shares@ US$6.809.8% of flowCommon StockSEC:0001104659-24-117942:0
9,169 shares@ US$38.2224.1% of flowCommon StockSEC:0001104659-24-037880:0
15,515 shares@ US$39.2241.7% of flowCommon StockSEC:0001104659-24-036312:0
33,750 shares0Common StockSEC:0001104659-24-026154:0
3,438 sharesCommon StockSEC:0001104659-24-022538:0
4,513 sharesCommon StockSEC:0001104659-24-010800:0
12,030 shares@ US$6.805.7% of flowCommon StockSEC:0001104659-23-119095:0
5,712 shares@ US$6.802.7% of flowCommon StockSEC:0001104659-23-117365:0
80 shares@ US$6.800.0% of flowCommon StockSEC:0001104659-23-115368:0
4,519 shares@ US$6.802.1% of flowCommon StockSEC:0001104659-23-099017:0
8,591 shares@ US$6.804.0% of flowCommon StockSEC:0001104659-23-089331:0